Top Sleep Experts Meet to Discuss CPAP Alternatives Following the Philips CPAP and BPAP Recalls
According to an online news article published on streetinsider.com, SomnoMed is holding a Sleep Research Society online focus group discussion on Thursday, July 29, 2021. The discussion will include a panel of approximately one dozen of the world’s leading clinical and academic sleep experts. The forum will meet to address the obstacles and facilitators for choosing non-PAP treatment strategies for obstructive sleep apnea (OSA) and Oral Appliance Therapy (OAT).
SomnoMed and the Sleep Research Society Foundation (SRSF) have placed their focus on non-CPAP alternatives following Philips’ recall of several CPAP and BPAP products.
According to Neil Verdal-Austin, SomnoMed’s CEO, the increasing awareness of the new challenges that PAP therapy patients face now for long-term OSA treatment success is the reason why there is a push to discuss alternative treatments for the millions of OSA sufferers. Mr. Verdal-Austin also stated that their partnership with the Sleep Research Society would help bring these conversations to the forefront and will help treat more OSA patients more effectively.
The panel of OSA clinicians and researchers will examine the role of custom-fitted, FDA-approved hypoglossal nerve stimulation and oral devices to treat obstructive sleep apnea. The forum will focus on various non-PAP treatment options and topics such as access to care, reimbursement, multi-disciplinary teams, health policies, expertise, treatment guidelines, regulatory aspects, and other issues related to the delivery of care. In light of the recent Philips PAP recall, the panel will address developing scientific findings and clinical reports to identify new research opportunities and knowledge gaps.
According to the news report, about 50% of OSA patients either discontinue or reject PAP therapy over time. This means around 50% of OSA sufferers leave their medical condition untreated. The American Association of Sleep Medicine (AASM), based on evidence-based guidelines, is in support of treatments using custom-fitted oral appliances as an adequate alternative for OSA patients who are not willing or are unable to bear PAP therapy. Fewer than 10% of OSA patients were prescribed or introduced to alternative therapies such as custom-fitted dental appliances.
CONTACT PARKER WAICHMAN LLP FOR A FREE CASE REVIEW
Were you or a loved one harmed by a defective breathing machine? Parker Waichman LLP helps families recover monetary compensation for harm caused by dangerous products. For your free consultation, contact our law firm today by using our live chat or calling 1-800-YOUR-LAWYER (1-800-968-7529).
New York | Brooklyn | Queens | Long Island | New Jersey | Florida
Call us at: 1-800-YOURLAWYER (800-968-7529) | Schedule your free consultation